Your browser doesn't support javascript.
loading
Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial.
Luger, Selina M; Wang, Victoria X; Rowe, Jacob M; Litzow, Mark R; Paietta, Elisabeth; Ketterling, Rhett P; Lazarus, Hillard; Rybka, Witold B; Craig, Michael D; Karp, Judith; Cooper, Brenda W; Makary, Adel Z; Kaminer, Lynne S; Appelbaum, Frederick R; Larson, Richard A; Tallman, Martin S.
Afiliação
  • Luger SM; Abramson Cancer Center, University of Pennsylvania, Perelman Center for Advanced Medicine, South Tower, 12th Floor, Philadelphia, PA, PA 19104, United States. Electronic address: Selina.luger@pennmedicine.upenn.edu.
  • Wang VX; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, AMA, United States.
  • Rowe JM; Rambam Medical Center, Haifa, Israel.
  • Litzow MR; Mayo Clinic, Rochester, MN, United States.
  • Paietta E; Montefiore Medical Center, Bronx, NY, United States.
  • Ketterling RP; Mayo Clinic, Rochester, MN, United States.
  • Lazarus H; Case Western Reserve University, Cleveland, OH, United States.
  • Rybka WB; Penn State Hershey Cancer Institute, Hershey, PA, United States.
  • Craig MD; West Virginia University Healthcare, Morgantown, WB, United States.
  • Karp J; Johns Hopkins University, Baltimore, MD, United States.
  • Cooper BW; Case Western Reserve University, Cleveland, OH, United States.
  • Makary AZ; Geisinger Medical Center, Danville, PA, United States.
  • Kaminer LS; North Shore Health System-Evanston Hospital, Evanston, IL, United States.
  • Appelbaum FR; Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
  • Larson RA; University of Chicago, Chicago, IL, United States.
  • Tallman MS; Northwestern University, Chicago, IL, United States(1); Memorial Sloan Kettering Cancer Center, NY, NY, United States(2).
Leuk Res ; 111: 106736, 2021 12.
Article em En | MEDLINE | ID: mdl-34773794
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_leukemia Assunto principal: Leucemia Mieloide Aguda / Quinolonas / Quimioterapia de Manutenção / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_leukemia Assunto principal: Leucemia Mieloide Aguda / Quinolonas / Quimioterapia de Manutenção / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2021 Tipo de documento: Article